Microglia in Nasu-Hakola Disease

Microglia in Nasu-Hakola Disease

Introduction

Pathway Diagram

Microglia in Nasu-Hakola Disease

Introduction

Pathway Diagram

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Microglia in Nasu-Hakola Disease</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Immune Cells</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Brain parenchyma, bone marrow</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Activated microglia, osteoclasts</td>
</tr>
<tr>
<td class="label">Key Genes</td>
<td>TREM2, TYROBP (DAP12)</td>
</tr>
<tr>
<td class="label">Inheritance</td>
<td>Autosomal recessive</td>
</tr>
<tr>
<td class="label">Prevalence</td>
<td><1:1,000,000</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000129](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000129](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>Onset</td>
</tr>
<tr>
<td class="label">Bone cysts</td>
<td>20-30 years</td>
</tr>
<tr>
<td class="label">Psychiatric symptoms</td>
<td>30-40 years</td>
</tr>
<tr>
<td class="label">Progressive dementia</td>
<td>40-50 years</td>
</tr>
<tr>
<td class="label">Motor symptoms</td>
<td>50+ years</td>
</tr>
</table>

Nasu-Hakola disease (NHD), also known as polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), is a rare autosomal recessive disorder caused by mutations in TREM2 or TYROBP genes["@paloneva2002"]. This disease uniquely connects microglial dysfunction to both bone and brain pathology, making it a crucial model for understanding microglia-mediated neurodegeneration.

Overview

<!-- taxonomy-enrichment -->

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: microglial cell (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000129)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)
• [OBO Foundry (CL:0000129)](http://purl.obolibrary.org/obo/CL_0000129)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000129)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)
• [OBO Foundry (CL:0000129)](http://purl.obolibrary.org/obo/CL_0000129)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Genetics and Molecular Pathogenesis

TREM2 Mutations

• Location: Chromosome 6p21.1
• Protein: Triggering receptor expressed on myeloid cells 2
• Function: Lipid sensing receptor on microglia
• Effect: Loss-of-function leads to impaired phagocytosis

TYROBP Mutations

• Location: Chromosome 19q13.12
• Protein: TYROBP (DAP12), adaptor protein
• Function: Signal transduction for TREM2
• Effect: Disrupts TREM2 signaling cascade

Molecular Cascade

Microglial Function in the Healthy Brain

Normal Microglia Roles

• Immune surveillance: Continuous process monitoring
• Phagocytosis: Clearance of debris, dead cells, aggregates
• Synaptic pruning: Developmental and pathological remodeling
• Cytokine signaling: Inflammation modulation
• Support functions: Metabolic support, trophic factor release

TREM2-Dependent Functions

TREM2 is critical for several microglial activities:

• Lipid metabolism: Sensing and processing myelin debris
• Amyloid clearance: Critical in Alzheimer's disease models
• Cell survival: Preventing apoptosis
• Proliferation: Response to brain injury

Role in Nasu-Hakola Disease

Microglial Pathology

The TREM2/TYROBP pathway is essential for microglial lipid sensing and phagocytosis[@griciuc2019]:

Phagocytic Impairment

• Myelin debris accumulation: Incomplete clearance
• Lipid droplet formation: Defective processing
• Lysosomal dysfunction: Autophagy impairment
• Cellular stress: ER stress, oxidative damage

Chronic Inflammation

• Cytokine dysregulation: Elevated IL-1β, TNF-α, IL-6
• Failed resolution: Persistent inflammatory state
• NLRP3 inflammasome: Hyperactivation

Neurodegeneration

• White matter lesions: Sclerosing leukoencephalopathy
• Cerebral atrophy: Progressive brain volume loss
• Demyelination: Primary pathology
• Neuronal loss: Secondary to gliosis

Bone Pathology

The same genes affect osteoclasts:

• Bone cysts: Polycystic changes in long bones
• Premenopausal fractures: Pathological fractures
• Impaired remodeling: Defective osteoclast function

Clinical Features

Therapeutic Implications

Current Approaches

• IL-1 antagonists (anakinra)
• TNF-α inhibitors

• Hematopoietic stem cell transplant
• Experimental ([Griciuc et al., Neuron 2019](https://doi.org/10.1016/j.neuron.2019.08.010))

• Cognitive enhancers
• Physical therapy

Emerging Therapies

• TREM2 agonists: Small molecule activators
• Gene therapy: AAV-mediated TREM2 delivery
• Microglial replacement: iPSC-derived microglia
• Lipid metabolism modulators: Targeting the primary defect

Research Directions

• Biomarkers: CSF biomarkers for early detection
• Imaging: PET ligands for microglial activation
• Genotype-phenotype correlations: Variable expressivity
• Therapeutic windows: Early intervention potential

Relationship to Alzheimer's Disease

NHD provides insights into AD pathogenesis[@griciuc2019]:

• TREM2 variants: AD risk factor (R47H, R62H)
• Microglial activation: Common pathway
• Lipid metabolism: Shared mechanisms
• Therapeutic translation: TREM2 as drug target

Animal Models

• Trem2 knockout mice: Microglial dysfunction
• Tyrobp knockout mice: Similar phenotype
• Human iPSC models: Patient-derived microglia
• Conditional knockouts: Cell-type specific studies

See Also

• [TREM2](/genes/trem2)
• [Neuroinflammation](/mechanisms/microglia-neuroinflammation)
• [/diseases/nasu-hakola-disease](/content/diseases)
• [Microglia](/cell-types/microglia)
• [/mechanisms/lipid-metabolism-neurodegeneration](/content/mechanisms)

External Links

• [NHD Registry](https://www.nhdregistry.org/) - Patient registry
• [OMIM - Nasu-Hakola](https://omim.org/) - Genetic information
• [PubMed - TREM2 NHD](https://pubmed.ncbi.nlm.nih.gov/) - Research literature

Background

The study of Microglia In Nasu Hakola Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Phase-Separated Organelle Targeting](/hypothesis/h-ec731b7a) — <span style="color:#81c784;font-weight:600">0.72</span> · Target: G3BP1
• [Purinergic P2Y12 Inverse Agonist Therapy](/hypothesis/h-f99ce4ca) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: P2RY12
• [Complement C1q Mimetic Decoy Therapy](/hypothesis/h-1fe4ba9b) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: C1QA
• [Metabolic Circuit Breaker via Lipid Droplet Modulation](/hypothesis/h-3d993b5d) — <span style="color:#81c784;font-weight:600">0.66</span> · Target: PLIN2
• [Temporal Decoupling via Circadian Clock Reset](/hypothesis/h-019ad538) — <span style="color:#81c784;font-weight:600">0.65</span> · Target: CLOCK
• [Fractalkine Axis Amplification via CX3CR1 Positive Allosteric Modulators](/hypothesis/h-ba3a948a) — <span style="color:#81c784;font-weight:600">0.63</span> · Target: CX3CR1
• [Synthetic Biology Rewiring via Orthogonal Receptors](/hypothesis/h-e3506e5a) — <span style="color:#ffd54f;font-weight:600">0.59</span> · Target: CNO
• [Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics](/hypothesis/h-513a633f) — <span style="color:#ffd54f;font-weight:600">0.58</span> · Target: ANXA1

Related Analyses:

• [TREM2 agonism vs antagonism in DAM microglia](/analysis/SDA-2026-04-01-gap-001) &#x1f504;
• [Microglial subtypes in neurodegeneration — friend vs foe](/analysis/SDA-2026-04-02-gap-microglial-subtypes-20260402004119) &#x1f504;
• [TREM2 agonism vs antagonism in DAM microglia](/analysis/SDA-2026-04-02-gap-001) &#x1f504;
• [Microglia-astrocyte crosstalk amplification loops in neurodegeneration](/analysis/SDA-2026-04-01-gap-009) &#x1f504;
• [Synaptic pruning by microglia in early AD](/analysis/SDA-2026-04-01-gap-v2-691b42f1) &#x1f504;

Pathway Diagram

The following diagram shows the key molecular relationships involving Microglia in Nasu-Hakola Disease discovered through SciDEX knowledge graph analysis: